Triple negative breast cancer (TNBC) represents an aggressive subtype of breast cancer,
which is deficient in estrogen receptor (ER), progesterone receptor (PR), and human …

Triple-negative breast cancer (TNBC) accounts for about 10-20% of all breast cancer cases
and is associated with an unfavorable prognosis. Until recently, treatment options for TNBC …

Although cannabinoids have been used for centuries for diverse pathological conditions,
recently, their clinical interest and application have emerged due to their diverse …

Breast cancer is the second leading cause of death among women. Although early
diagnosis and development of new treatments have improved their prognosis, many patients …

Breast cancer is a very common disease that affects approximately 1 in 10 women at some
point in their lives. Importantly, breast cancer cannot be considered a single disease as it is …

Cannabinoids (CBs) from Cannabis sativa provide relief for tumor-associated symptoms
(including nausea, anorexia, and neuropathic pain) in the palliative treatment of cancer …

Breast cancer (BC) is the most common cancer in women worldwide. Approximately 70–
80% of BCs express estrogen receptors (ER), which predict the response to endocrine …

Introduction: The term 'cannabinoids' designates a family of compounds with activity upon
cannabinoid receptors. Cannabinoids are classified in three groups: phytocannabinoids …

Cannabinoids, commonly used for medicinal and recreational purposes, consist of various
complex hydrophobic molecules obtained from Cannabis sativa L. Acting as an inhibitory …

Cannabinoids, the active components of the hemp plant Cannabis sativa, along with their
endogenous counterparts and synthetic derivatives, have elicited anti-cancer effects in many …